Medical treatment of glaucoma began in the late 1800s, using physostigmine and pilocarpine. In the US, the treatment of glaucoma usually begins with the appointment of local drugs.
It is now clear that pathophysiologically glaucoma is a progressive loss of ganglion cells due to an increase in intraocular pressure, which leads to the appearance of visual field defects.
